Whybra C - Search Results

1

Successful pregnancy outcome in a patient with Fabry disease receiving enzyme replacement therapy with agalsidase alfa.

Wendt S, Whybra C, Kampmann C, Teichmann E, Beck M. Wendt S, et al. Among authors: whybra c. J Inherit Metab Dis. 2005;28(5):787-8. doi: 10.1007/s10545-005-0018-9. J Inherit Metab Dis. 2005. PMID: 16151910

2

A 4-year study of the efficacy and tolerability of enzyme replacement therapy with agalsidase alfa in 36 women with Fabry disease.

Whybra C, Miebach E, Mengel E, Gal A, Baron K, Beck M, Kampmann C. Whybra C, et al. Genet Med. 2009 Jun;11(6):441-9. doi: 10.1097/GIM.0b013e3181a23bec. Genet Med. 2009. PMID: 19346951 Free article. Clinical Trial.

3

Angiokeratoma and pain, but not Fabry's disease: considerations for differential diagnosis.

Ries M, Wendrich K, Whybra C, Kampmann C, Gal A, Beck M. Ries M, et al. Among authors: whybra c. Contrib Nephrol. 2001;(136):256-9. doi: 10.1159/000060198. Contrib Nephrol. 2001. PMID: 11688390 No abstract available.

4

Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes.

Whybra C, Kampmann C, Willers I, Davies J, Winchester B, Kriegsmann J, Brühl K, Gal A, Bunge S, Beck M. Whybra C, et al. J Inherit Metab Dis. 2001 Dec;24(7):715-24. doi: 10.1023/a:1012993305223. J Inherit Metab Dis. 2001. PMID: 11804208

5

Enzyme replacement therapy in heterozygous females with Fabry disease: results of a phase IIIB study.

Baehner F, Kampmann C, Whybra C, Miebach E, Wiethoff CM, Beck M. Baehner F, et al. Among authors: whybra c. J Inherit Metab Dis. 2003;26(7):617-27. doi: 10.1023/b:boli.0000005658.14563.77. J Inherit Metab Dis. 2003. PMID: 14707510 Clinical Trial.

6

The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy.

Whybra C, Kampmann C, Krummenauer F, Ries M, Mengel E, Miebach E, Baehner F, Kim K, Bajbouj M, Schwarting A, Gal A, Beck M. Whybra C, et al. Clin Genet. 2004 Apr;65(4):299-307. doi: 10.1111/j.1399-0004.2004.00219.x. Clin Genet. 2004. PMID: 15025723

7

Cumulative incidence rates of the mucopolysaccharidoses in Germany.

Baehner F, Schmiedeskamp C, Krummenauer F, Miebach E, Bajbouj M, Whybra C, Kohlschütter A, Kampmann C, Beck M. Baehner F, et al. Among authors: whybra c. J Inherit Metab Dis. 2005;28(6):1011-7. doi: 10.1007/s10545-005-0112-z. J Inherit Metab Dis. 2005. PMID: 16435194

8

The right ventricle in Fabry disease.

Kampmann C, Baehner FA, Whybra C, Bajbouj M, Baron K, Knuf M, Wiethoff CM, Trübel H, Beck M. Kampmann C, et al. Among authors: whybra c. Acta Paediatr Suppl. 2005 Mar;94(447):15-8; discussion 9-10. doi: 10.1111/j.1651-2227.2005.tb02104.x. Acta Paediatr Suppl. 2005. PMID: 15895706

9

Cardiac manifestations of Anderson-Fabry disease in heterozygous females.

Kampmann C, Baehner F, Whybra C, Martin C, Wiethoff CM, Ries M, Gal A, Beck M. Kampmann C, et al. Among authors: whybra c. J Am Coll Cardiol. 2002 Nov 6;40(9):1668-74. doi: 10.1016/s0735-1097(02)02380-x. J Am Coll Cardiol. 2002. PMID: 12427421 Free article.

10

The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents.

Ries M, Ramaswami U, Parini R, Lindblad B, Whybra C, Willers I, Gal A, Beck M. Ries M, et al. Among authors: whybra c. Eur J Pediatr. 2003 Nov;162(11):767-72. doi: 10.1007/s00431-003-1299-3. Epub 2003 Sep 20. Eur J Pediatr. 2003. PMID: 14505049

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page